Clinical Trial Update: A Study of OPC-262 in Patients With Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluating OPC-262 in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OPC-262

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Diabetes Type 2 | Phase 2, Phase 3 | Status: COMPLETED